These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2575371)

  • 1. The differential diagnosis of negative symptoms in chronic schizophrenia.
    Whiteford HA; Peabody CA
    Aust N Z J Psychiatry; 1989 Dec; 23(4):491-6. PubMed ID: 2575371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative symptoms in schizophrenia.
    Duff V; Olders H
    Can J Psychiatry; 1990 Aug; 35(6):570-1. PubMed ID: 1976430
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary negative symptoms - A review of mechanisms, assessment and treatment.
    Kirschner M; Aleman A; Kaiser S
    Schizophr Res; 2017 Aug; 186():29-38. PubMed ID: 27230288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dissociative identity disorder or schizophrenia?].
    Tschöke S; Steinert T
    Fortschr Neurol Psychiatr; 2010 Jan; 78(1):33-7. PubMed ID: 19847739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic presentation and initial treatment for schizophrenia in children and adolescents.
    Correll CU
    J Clin Psychiatry; 2010 Nov; 71(11):e29. PubMed ID: 21114942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of negative symptoms.
    Carpenter WT; Heinrichs DW; Alphs LD
    Schizophr Bull; 1985; 11(3):440-52. PubMed ID: 2863871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of schizophrenia with substance use disorders.
    Lybrand J; Caroff S
    Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 3():9-13; discussion 47. PubMed ID: 8626371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paranoid personality disorder and the schizophrenia spectrum-Where to draw the line?
    Birkeland SF
    Personal Ment Health; 2013 Aug; 7(3):254-8. PubMed ID: 24343968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older people with chronic schizophrenia.
    Karim S; Overshott R; Burns A
    Aging Ment Health; 2005 Jul; 9(4):315-24. PubMed ID: 16019287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostics and therapy of depressive symptoms in schizophrenic patients].
    Bottlender R; Hampel H; Sievers M; Möller HJ
    MMW Fortschr Med; 2005 May; 147 Spec No 2():59-62. PubMed ID: 15968875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis of psychotic symptoms in adolescents and young adults with borderline personality disorder].
    Dammann G; Walter M
    Psychiatr Prax; 2003 Sep; 30(6):304-11. PubMed ID: 12970815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.
    Siris SG
    Am J Psychiatry; 2000 Sep; 157(9):1379-89. PubMed ID: 10964850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three-dimensional ultrasonic movement analysis of gait and hand-movements in schizophrenic patients].
    Putzhammer A; Perfahl M; Pfeiff L; Müller JL
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S38-42. PubMed ID: 15818519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compliance with treatment in schizophrenia and mood disorders].
    Sorvaniemi M; Kampman O
    Duodecim; 2000; 116(3):277-84. PubMed ID: 11764451
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.